HENDERSON MICHAEL THOMAS bought SYRE
January 21, 2026 · Form 4 insider transaction
HENDERSON MICHAEL THOMAS bought 63,227 shares of Spyre Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
63,227
Price
$0.00
Total value
N/A
InsiderHENDERSON MICHAEL THOMAS
RoleOfficer, Director
SecurityCommon Stock
Transaction codeJ: J
Transaction dateJanuary 21, 2026
Filing dateJanuary 23, 2026
Shares owned after168,606
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the pro-rata distribution of shares of common stock for no consideration from a limited liability company in which the Reporting Person is a member.